Pharmaceutical company AstraZeneca has reached a $486 million deal with the US government to supply as many as 100,000 doses of its experimental COVID-19 antibody treatment, if it's ultimately approved. Under the terms of the agreement, the U.S. Department of Health and Human Services will supply the funding as part of the Trump administration's Operation Warp Speed effort to quickly develop potential vaccines and treatments for COVID-19. Source: UPI. 12/10/2020